Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
The $500B Stargate Initiative, led by Trump, OpenAI, SoftBank, and Oracle, is set to revolutionize U.S. AI infrastructure.